AU1299295A - Improved efficacy of alpha-helical cytokines - Google Patents

Improved efficacy of alpha-helical cytokines

Info

Publication number
AU1299295A
AU1299295A AU12992/95A AU1299295A AU1299295A AU 1299295 A AU1299295 A AU 1299295A AU 12992/95 A AU12992/95 A AU 12992/95A AU 1299295 A AU1299295 A AU 1299295A AU 1299295 A AU1299295 A AU 1299295A
Authority
AU
Australia
Prior art keywords
alpha
improved efficacy
helical cytokines
cytokines
helical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12992/95A
Other languages
English (en)
Inventor
Azad Bonni
David A Frank
Michael E Greenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of AU1299295A publication Critical patent/AU1299295A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/217IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU12992/95A 1993-12-02 1994-12-02 Improved efficacy of alpha-helical cytokines Abandoned AU1299295A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16167293A 1993-12-02 1993-12-02
US161672 1993-12-02
PCT/US1994/013836 WO1995015177A2 (fr) 1993-12-02 1994-12-02 Renforcement de l'efficacite des cytokines a helice alpha

Publications (1)

Publication Number Publication Date
AU1299295A true AU1299295A (en) 1995-06-19

Family

ID=22582224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12992/95A Abandoned AU1299295A (en) 1993-12-02 1994-12-02 Improved efficacy of alpha-helical cytokines

Country Status (2)

Country Link
AU (1) AU1299295A (fr)
WO (1) WO1995015177A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106795494A (zh) * 2014-08-27 2017-05-31 首尔大学校产学协力团 从干细胞分化为视网膜神经节细胞的方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19604858A1 (de) * 1996-02-10 1997-08-14 Boehringer Ingelheim Int Verwendung von Interferon-gamma (IFN-gamma) zur Herstellung einer pharmazeutischen Präparation zur Prophylaxe und/oder Behandlung von Erkrankungen, die mit einer Überexpression von Amyloid-Vorläuferprotein einhergehen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99497A (en) * 1990-10-01 1997-03-18 Res Dev Foundation Synergistic compositions comprising tnf and il-4
US5372808A (en) * 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
JP3496937B2 (ja) * 1990-10-17 2004-02-16 アムジエン・インコーポレーテツド コンセンサスヒトインターフェロンを含有する細胞増殖障害治療用の医用組成物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106795494A (zh) * 2014-08-27 2017-05-31 首尔大学校产学协力团 从干细胞分化为视网膜神经节细胞的方法
CN106795494B (zh) * 2014-08-27 2021-11-02 克拉维斯治疗公司 从干细胞分化为视网膜神经节细胞的方法

Also Published As

Publication number Publication date
WO1995015177A2 (fr) 1995-06-08
WO1995015177A3 (fr) 1995-09-14

Similar Documents

Publication Publication Date Title
AU669350B2 (en) Electrode
AU4166393A (en) Auto-reclosers
AU4013193A (en) Method of maintaining relationships between elements
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU3042892A (en) Rockbolt
AU5201293A (en) Debrominative chlorination of pyrroles
AU4177593A (en) Benzophenonehydrazones
AU685767B2 (en) Substituted benzazepinones
AU667580B2 (en) Line-handling block
AU4156393A (en) Heterocyclyltriazolinones
AU6723294A (en) Use of simmondsine
AU664253B2 (en) Photo-deviometer
AU3461693A (en) Saddle-cloth
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU4164793A (en) Heterocyclyltriazolinones
AU4632493A (en) Weathershed
AU5371694A (en) Use of the tarchonanthus camphoratus
AU1299295A (en) Improved efficacy of alpha-helical cytokines
AU3185693A (en) Pyrrolylbenzodiazepinones
AU4864693A (en) Alkoxymethyl-substituted pyridonebiphenyls
AU3895593A (en) Biocatalysis
AU3338293A (en) Trickle alumina feeder
AU4316993A (en) Polyaniles
AU5564794A (en) Play-mark